TY - BOOK PY - 2015 DA - 2015// TI - SEER Cancer Statistics Review, 1975–201 PB - National Cancer Institute CY - Bethesda, MD ID - ref1 ER - TY - JOUR AU - Valkema, R. AU - Pauwels, S. AU - Kvols, L. K. AU - Barone, R. AU - Jamar, F. AU - Bakker, W. H. PY - 2006 DA - 2006// TI - Survival and response after peptide receptor radionuclide therapy with [90Y-DOTA0,Tyr3]octreotide in patients with advanced gastroenteropancreatic neuroendocrine tumors JO - Semin Nucl Med VL - 36 UR - https://doi.org/10.1053/j.semnuclmed.2006.01.001 DO - 10.1053/j.semnuclmed.2006.01.001 ID - Valkema2006 ER - TY - JOUR AU - Kwekkeboom, D. J. AU - Herder, W. W. AU - Kam, B. L. AU - Eijck, C. H. AU - Essen, M. AU - Kooij, P. P. PY - 2008 DA - 2008// TI - Treatment with the radiolabeled somatostatin analog [177 Lu-DOTA 0,Tyr3]octreotate: toxicity, efficacy, and survival JO - J Clin Oncol VL - 26 UR - https://doi.org/10.1200/JCO.2007.15.2553 DO - 10.1200/JCO.2007.15.2553 ID - Kwekkeboom2008 ER - TY - JOUR AU - Imhof, A. AU - Brunner, P. AU - Marincek, N. AU - Briel, M. AU - Schindler, C. AU - Rasch, H. PY - 2011 DA - 2011// TI - Response, survival, and long-term toxicity after therapy with the radiolabeled somatostatin analogue [90Y-DOTA]-TOC in metastasized neuroendocrine cancers JO - J Clin Oncol VL - 29 UR - https://doi.org/10.1200/JCO.2010.33.7873 DO - 10.1200/JCO.2010.33.7873 ID - Imhof2011 ER - TY - JOUR AU - Kwekkeboom, D. J. AU - Teunissen, J. J. AU - Bakker, W. H. AU - Kooij, P. P. AU - Herder, W. W. AU - Feelders, R. A. PY - 2005 DA - 2005// TI - Radiolabeled somatostatin analog [177Lu-DOTA0,Tyr3]octreotate in patients with endocrine gastroenteropancreatic tumors JO - J Clin Oncol VL - 23 UR - https://doi.org/10.1200/JCO.2005.08.066 DO - 10.1200/JCO.2005.08.066 ID - Kwekkeboom2005 ER - TY - JOUR AU - Bodei, L. AU - Cremonesi, M. AU - Grana, C. M. AU - Fazio, N. AU - Iodice, S. AU - Baio, S. M. PY - 2011 DA - 2011// TI - Peptide receptor radionuclide therapy with (1)Lu-DOTATATE: the IEO phase I-II study JO - Eur J Nucl Med Mol Imaging VL - 38 UR - https://doi.org/10.1007/s00259-011-1902-1 DO - 10.1007/s00259-011-1902-1 ID - Bodei2011 ER - TY - JOUR AU - Gabriel, M. AU - Andergassen, U. AU - Putzer, D. AU - Kroiss, A. AU - Waitz, D. AU - Guggenberg, E. PY - 2010 DA - 2010// TI - Individualized peptide-related-radionuclide-therapy concept using different radiolabelled somatostatin analogs in advanced cancer patients JO - Q J Nucl Med Mol Imaging VL - 54 ID - Gabriel2010 ER - TY - JOUR AU - Pauwels, S. AU - Barone, R. AU - Walrand, S. AU - Borson-Chazot, F. AU - Valkema, R. AU - Kvols, L. K. PY - 2005 DA - 2005// TI - Practical dosimetry of peptide receptor radionuclide therapy with (90)Y-labeled somatostatin analogs JO - J Nucl Med VL - 46 Suppl 1 ID - Pauwels2005 ER - TY - JOUR AU - Ilan, E. AU - Sandstrom, M. AU - Wassberg, C. AU - Sundin, A. AU - Garske-Roman, U. AU - Eriksson, B. PY - 2015 DA - 2015// TI - Dose response of pancreatic neuroendocrine tumors treated with peptide receptor radionuclide therapy using 177Lu-DOTATATE JO - J Nucl Med VL - 56 UR - https://doi.org/10.2967/jnumed.114.148437 DO - 10.2967/jnumed.114.148437 ID - Ilan2015 ER - TY - JOUR AU - Williams, L. E. AU - DeNardo, G. L. AU - Meredith, R. F. PY - 2008 DA - 2008// TI - Targeted radionuclide therapy JO - Med Phys VL - 35 UR - https://doi.org/10.1118/1.2938520 DO - 10.1118/1.2938520 ID - Williams2008 ER - TY - JOUR AU - Moll, S. AU - Nickeleit, V. AU - Mueller-Brand, J. AU - Brunner, F. P. AU - Maecke, H. R. AU - Mihatsch, M. J. PY - 2001 DA - 2001// TI - A new cause of renal thrombotic microangiopathy: yttrium 90-DOTATOC internal radiotherapy JO - Am J Kidney Dis VL - 37 UR - https://doi.org/10.1016/S0272-6386(01)80135-9 DO - 10.1016/S0272-6386(01)80135-9 ID - Moll2001 ER - TY - JOUR AU - Valkema, R. AU - Pauwels, S. A. AU - Kvols, L. K. AU - Kwekkeboom, D. J. AU - Jamar, F. AU - Jong, M. PY - 2005 DA - 2005// TI - Long-term follow-up of renal function after peptide receptor radiation therapy with (90)Y-DOTA(0), Tyr(3)-octreotide and (177)Lu-DOTA(0), Tyr(3)-octreotate JO - J Nucl Med VL - 46 ID - Valkema2005 ER - TY - JOUR AU - Bodei, L. AU - Cremonesi, M. AU - Grana, C. AU - Rocca, P. AU - Bartolomei, M. AU - Chinol, M. PY - 2004 DA - 2004// TI - Receptor radionuclide therapy with 90Y-[DOTA]0-Tyr3-octreotide (90Y-DOTATOC) in neuroendocrine tumours JO - Eur J Nucl Med Mol Imaging VL - 31 UR - https://doi.org/10.1007/s00259-004-1571-4 DO - 10.1007/s00259-004-1571-4 ID - Bodei2004 ER - TY - JOUR AU - Bodei, L. AU - Cremonesi, M. AU - Ferrari, M. AU - Pacifici, M. AU - Grana, C. M. AU - Bartolomei, M. PY - 2008 DA - 2008// TI - Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors JO - Eur J Nucl Med Mol Imaging VL - 35 UR - https://doi.org/10.1007/s00259-008-0778-1 DO - 10.1007/s00259-008-0778-1 ID - Bodei2008 ER - TY - JOUR AU - Sandstrom, M. AU - Garske-Roman, U. AU - Granberg, D. AU - Johansson, S. AU - Widstrom, C. AU - Eriksson, B. PY - 2013 DA - 2013// TI - Individualized dosimetry of kidney and bone marrow in patients undergoing 177Lu-DOTA-octreotate treatment JO - J Nucl Med VL - 54 UR - https://doi.org/10.2967/jnumed.112.107524 DO - 10.2967/jnumed.112.107524 ID - Sandstrom2013 ER - TY - JOUR AU - Sabet, A. AU - Ezziddin, K. AU - Pape, U. F. AU - Reichman, K. AU - Haslerud, T. AU - Ahmadzadehfar, H. PY - 2014 DA - 2014// TI - Accurate assessment of long-term nephrotoxicity after peptide receptor radionuclide therapy with (177)Lu-octreotate JO - Eur J Nucl Med Mol Imaging VL - 41 UR - https://doi.org/10.1007/s00259-013-2601-x DO - 10.1007/s00259-013-2601-x ID - Sabet2014 ER - TY - JOUR AU - Bodei, L. AU - Kidd, M. AU - Paganelli, G. AU - Grana, C. M. AU - Drozdov, I. AU - Cremonesi, M. PY - 2015 DA - 2015// TI - Long-term tolerability of PRRT in 807 patients with neuroendocrine tumours: the value and limitations of clinical factors JO - Eur J Nucl Med Mol Imaging VL - 42 UR - https://doi.org/10.1007/s00259-014-2893-5 DO - 10.1007/s00259-014-2893-5 ID - Bodei2015 ER - TY - JOUR AU - Emami, B. AU - Lyman, J. AU - Brown, A. AU - Coia, L. AU - Goitein, M. AU - Munzenrider, J. E. PY - 1991 DA - 1991// TI - Tolerance of normal tissue to therapeutic irradiation JO - Int J Radiat Oncol Biol Phys VL - 21 UR - https://doi.org/10.1016/0360-3016(91)90171-Y DO - 10.1016/0360-3016(91)90171-Y ID - Emami1991 ER - TY - JOUR AU - Konijnenberg, M. AU - Melis, M. AU - Valkema, R. AU - Krenning, E. AU - Jong, M. PY - 2007 DA - 2007// TI - Radiation dose distribution in human kidneys by octreotides in peptide receptor radionuclide therapy JO - J Nucl Med VL - 48 ID - Konijnenberg2007 ER - TY - JOUR AU - Barone, R. AU - Borson-Chazot, F. AU - Valkema, R. AU - Walrand, S. AU - Chauvin, F. AU - Gogou, L. PY - 2005 DA - 2005// TI - Patient-specific dosimetry in predicting renal toxicity with (90)Y-DOTATOC: relevance of kidney volume and dose rate in finding a dose-effect relationship JO - J Nucl Med VL - 46 Suppl 1 ID - Barone2005 ER - TY - JOUR AU - Sandstrom, M. AU - Garske, U. AU - Granberg, D. AU - Sundin, A. AU - Lundqvist, H. PY - 2010 DA - 2010// TI - Individualized dosimetry in patients undergoing therapy with (177)Lu-DOTA-D-Phe (1)-Tyr (3)-octreotate JO - Eur J Nucl Med Mol Imaging VL - 37 UR - https://doi.org/10.1007/s00259-009-1216-8 DO - 10.1007/s00259-009-1216-8 ID - Sandstrom2010 ER - TY - JOUR AU - Ljungberg, M. AU - Sjogreen-Gleisner, K. PY - 2011 DA - 2011// TI - The accuracy of absorbed dose estimates in tumours determined by quantitative SPECT: a Monte Carlo study JO - Acta Oncol VL - 50 UR - https://doi.org/10.3109/0284186X.2011.584559 DO - 10.3109/0284186X.2011.584559 ID - Ljungberg2011 ER - TY - STD TI - Sandstrom M, Garske-Román U, Granberg D, Widstrom C, Eriksson B, Sundin A, et al. Absorbed doses from cross-fire to solid organs in 300 patients undergoing therapy with 177Lu-octreotate. SNMMI 60th annual meeting. Vancouver: The journal of nuclear medicine; 2013;(Supp 2), p. 255P. ID - ref23 ER - TY - JOUR AU - Erdi, Y. E. AU - Wessels, B. W. AU - Loew, M. H. AU - Erdi, A. K. PY - 1995 DA - 1995// TI - Threshold estimation in single photon emission computed tomography and planar imaging for clinical radioimmunotherapy JO - Cancer Res VL - 55 ID - Erdi1995 ER - TY - JOUR AU - Boellaard, R. AU - Hoekstra, O. AU - Lammertsma, A. PY - 2008 DA - 2008// TI - Software tools for standardized analysis of FDG whole body studies in multi-center trials JO - J Nucl Med VL - 49 ID - Boellaard2008 ER - TY - JOUR AU - Prasad, V. AU - Bodei, L. AU - Kidd, M. AU - Modlin, I. M. PY - 2014 DA - 2014// TI - Whither peptide receptor radionuclide therapy for neuroendocrine tumors: an Einsteinian view of the facts and myths JO - Eur J Nucl Med Mol Imaging VL - 41 UR - https://doi.org/10.1007/s00259-014-2780-0 DO - 10.1007/s00259-014-2780-0 ID - Prasad2014 ER - TY - JOUR AU - Cremonesi, M. AU - Botta, F. AU - Dia, A. AU - Ferrari, M. AU - Bodei, L. AU - Cicco, C. PY - 2010 DA - 2010// TI - Dosimetry for treatment with radiolabelled somatostatin analogues. A review JO - Q J Nucl Med Mol Imaging VL - 54 ID - Cremonesi2010 ER - TY - JOUR AU - Garkavij, M. AU - Nickel, M. AU - Sjogreen-Gleisner, K. AU - Ljungberg, M. AU - Ohlsson, T. AU - Wingardh, K. PY - 2010 DA - 2010// TI - 177Lu-[DOTA0, Tyr3] octreotate therapy in patients with disseminated neuroendocrine tumors: Analysis of dosimetry with impact on future therapeutic strategy JO - Cancer VL - 116 UR - https://doi.org/10.1002/cncr.24796 DO - 10.1002/cncr.24796 ID - Garkavij2010 ER - TY - JOUR AU - Wehrmann, C. AU - Senftleben, S. AU - Zachert, C. AU - Muller, D. AU - Baum, R. P. PY - 2007 DA - 2007// TI - Results of individual patient dosimetry in peptide receptor radionuclide therapy with 177Lu DOTA-TATE and 177Lu DOTA-NOC JO - Cancer Biother Radiopharm VL - 22 UR - https://doi.org/10.1089/cbr.2006.325 DO - 10.1089/cbr.2006.325 ID - Wehrmann2007 ER - TY - JOUR AU - Cheong, B. AU - Muthupillai, R. AU - Rubin, M. F. AU - Flamm, S. D. PY - 2007 DA - 2007// TI - Normal values for renal length and volume as measured by magnetic resonance imaging JO - Clin J Am Soc Nephrol VL - 2 UR - https://doi.org/10.2215/CJN.00930306 DO - 10.2215/CJN.00930306 ID - Cheong2007 ER - TY - STD TI - Gröne, H, Thomas, C, editor. Harnapparat - Männliches Genitale. Grundlagen der Klinischen Medizin, volume 6. Schattauer, Stuttgart; 1993. ID - ref31 ER - TY - JOUR AU - Sward, C. AU - Bernhardt, P. AU - Ahlman, H. AU - Wangberg, B. AU - Forssell-Aronsson, E. AU - Larsson, M. PY - 2010 DA - 2010// TI - [177Lu-DOTA 0-Tyr 3]-octreotate treatment in patients with disseminated gastroenteropancreatic neuroendocrine tumors: the value of measuring absorbed dose to the kidney JO - World J Surg VL - 34 UR - https://doi.org/10.1007/s00268-009-0387-6 DO - 10.1007/s00268-009-0387-6 ID - Sward2010 ER - TY - JOUR AU - Larsson, M. AU - Bernhardt, P. AU - Svensson, J. B. AU - Wangberg, B. AU - Ahlman, H. AU - Forssell-Aronsson, E. PY - 2012 DA - 2012// TI - Estimation of absorbed dose to the kidneys in patients after treatment with 177Lu-octreotate: comparison between methods based on planar scintigraphy JO - EJNMMI Res VL - 2 UR - https://doi.org/10.1186/2191-219X-2-49 DO - 10.1186/2191-219X-2-49 ID - Larsson2012 ER -